Y. Kinoshita

发表

Patients with FGF23-related hypophosphatemic rickets/osteomalacia do not present with left ventricular hypertrophy

Y. Takashi, S. Fukumoto, M. Taguchi, 2017, Endocrine research.

Altered Thyroid Function Tests Observed in Hypophosphatasia Patients Treated with Asfotase Alfa

M. Nangaku, N. Makita, Y. Kinoshita, 2021, International journal of endocrinology.

High serum ALP level is associated with increased risk of denosumab-related hypocalcemia in patients with bone metastases from solid tumors.

M. Nangaku, Y. Takashi, S. Fukumoto, 2016, Endocrine journal.

after successful pituitary surgery if pancreatic β-cell function is preserved

S. Yamada, Y. Takeuchi, H. Fujii, 2011 .

Gene Therapy Using Adeno‐Associated Virus Serotype 8 Encoding TNAP‐D10 Improves the Skeletal and Dentoalveolar Phenotypes in Alpl −/− Mice

J. Millán, K. Miyake, B. Foster, 2021, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Clinical Challenges in Diagnosis, Tumor Localization and Treatment of Tumor‐Induced Osteomalacia: Outcome of a Retrospective Surveillance

M. Nangaku, K. Ohnaka, Y. Takeuchi, 2022, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Ectopic expression of Klotho in fibroblast growth factor 23 (FGF23)-producing tumors that cause tumor-induced rickets/osteomalacia (TIO)

H. Mano, M. Nangaku, M. Fukayama, 2018, Bone reports.

Phosphate enhances Fgf23 expression through reactive oxygen species in UMR-106 cells

S. Fukumoto, M. Taguchi, Y. Kinoshita, 2016, Journal of Bone and Mineral Metabolism.

Vitamin D insufficiency underlies unexpected hypocalcemia following high dose glucocorticoid therapy.

Y. Takeuchi, K. Masuoka, S. Miyakoshi, 2008, Bone.

Mutational analysis of patients with FGF23-related hypophosphatemic rickets.

T. Fujita, S. Fukumoto, T. Igarashi, 2012, European journal of endocrinology.

Functional activities of mutant calcium-sensing receptors determine clinical presentations in patients with autosomal dominant hypocalcemia.

Sumiyo Watanabe, S. Fukumoto, M. Taguchi, 2014, The Journal of clinical endocrinology and metabolism.

[Case report; A case of FGF23-related hypophosphatemic osteomalacia caused by long-term administration of saccharated ferric oxide].

T. Fujita, S. Fukumoto, M. Taguchi, 2011, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

Identification of ENPP1 Haploinsufficiency in Patients With Diffuse Idiopathic Skeletal Hyperostosis and Early‐Onset Osteoporosis

M. Nangaku, D. Braddock, T. Takamura, 2022, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Changes in bone metabolic parameters following oral calcium supplementation in an adult patient with vitamin D-dependent rickets type 2A.

M. Nangaku, S. Fukumoto, N. Makita, 2017, Endocrine journal.

Functional analysis of mutant FAM20C in Raine syndrome with FGF23-related hypophosphatemia.

S. Fukumoto, M. Taguchi, Y. Kinoshita, 2014, Bone.

Tumor-induced Osteomalacia Caused by a Parotid Tumor

M. Nangaku, Y. Takashi, N. Egami, 2017, Internal medicine.

Rapid Recovery of Hypothalamic-Pituitary Axis after Successful Resection of an ACTH-secreting Neuroendocrine Tumor.

Katsutoshi Takahashi, M. Nangaku, Y. Takashi, 2015, Internal medicine.

[Anti-FGF23 antibody therapy for patients with tumor-induced osteomalacia].

S. Fukumoto, Y. Kinoshita, 2014, Clinical calcium.

Induction of FGF23-related hypophosphatemic osteomalacia by alcohol consumption

M. Nangaku, M. Katsura, S. Fukumoto, 2021, Bone reports.

Prevalence and clinical outcomes of hip fractures and subchondral insufficiency fractures of the femoral head in patients with tumour-induced osteomalacia

Sakae Tanaka, S. Fukumoto, T. Akiyama, 2017, International Orthopaedics.

Activation of unliganded FGF receptor by extracellular phosphate potentiates proteolytic protection of FGF23 by its O-glycosylation

M. Matsuhisa, M. Nangaku, S. Kato, 2019, Proceedings of the National Academy of Sciences.

Effectiveness and safety of cinacalcet for primary hyperparathyroidism: a single center experience.

M. Nangaku, M. Fujita, N. Makita, 2019, Endocrine journal.

Hypophosphatemic osteomalacia and bone sclerosis caused by a novel homozygous mutation of the FAM20C gene in an elderly man with a mild variant of Raine syndrome.

F. Glorieux, K. Ozono, Y. Imanishi, 2014, Bone.

Massive calcification around large joints in a patient subsequently diagnosed with adult-onset hypophosphatasia

M. Nangaku, N. Makita, Y. Kinoshita, 2021, Osteoporosis International.

X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment.

S. Fukumoto, Y. Kinoshita, 2018, Endocrine reviews.

Gene Therapy Using Recombinant AAV Type 8 Vector Encoding TNAP‐D10 Improves the Skeletal Phenotypes in Murine Models of Osteomalacia

J. Millán, C. Farquharson, K. Miyake, 2022, JBMR plus.

Utility of Multimodality Approach Including Systemic FGF23 Venous Sampling in Localizing Phosphaturic Mesenchymal Tumors

M. Nangaku, Y. Takashi, M. Katsura, 2022, Journal of the Endocrine Society.

Impaired glucose metabolism in Japanese patients with acromegaly is restored after successful pituitary surgery if pancreatic {beta}-cell function is preserved.

S. Yamada, Y. Takeuchi, H. Fujii, 2011, European journal of endocrinology.

Radiological evaluation of pseudofracture after the administration of asfotase alfa in an adult with benign prenatal hypophosphatasia: A case report

M. Nangaku, N. Makita, Y. Kinoshita, 2021, Bone reports.

1,25-dihydroxyvitamin D suppresses circulating levels of parathyroid hormone in a patient with primary hyperparathyroidism and coexistent sarcoidosis.

Y. Takeuchi, A. Takeshita, D. Miura, 2005, The Journal of clinical endocrinology and metabolism.

Incidence of complications in 25 adult patients with X-linked hypophosphatemia.

M. Nangaku, Y. Taniguchi, S. Fukumoto, 2021, The Journal of clinical endocrinology and metabolism.

Effect of conventional treatment on dental complications and ectopic ossifications among 30 adults with XLH.

M. Nangaku, T. Ogasawara, Y. Taniguchi, 2022, The Journal of clinical endocrinology and metabolism.

[Inhitibion of FGF23 activities as a possible new treatment for patients with FGF23-related hypophosphatemic diseases].

Y. Kinoshita, 2016, Clinical calcium.

Ectopic expression of Klotho in fibroblast growth factor 23 (FGF23)-producing tumors that cause tumor-induced rickets/osteomalacia (TIO)

H. Mano, M. Nangaku, M. Fukayama, 2018, Bone Reports.

Impaired glucose metabolism in Japanese patients with acromegaly is restored after successful pituitary surgery if pancreatic {beta}-cell function is preserved.

S. Yamada, Y. Takeuchi, H. Fujii, 2011, European journal of endocrinology.

Dentoalveolar Alterations in an Adenine‐Induced Chronic Kidney Disease Mouse Model

J. Millán, E. Chu, B. Foster, 2023, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The Effect of Asfotase Alfa on Plasma and Urine Pyrophosphate Levels and Pseudofractures in a Patient With Adult‐Onset Hypophosphatasia

M. Nangaku, Kanako Tachikawa, T. Michigami, 2023, JBMR plus.

Functional activities of mutant calcium-sensing receptors determine clinical presentations in patients with autosomal dominant hypocalcemia.

Sumiyo Watanabe, S. Fukumoto, M. Taguchi, 2014, The Journal of clinical endocrinology and metabolism.

Hypophosphatemic osteomalacia and bone sclerosis caused by a novel homozygous mutation of the FAM20C gene in an elderly man with a mild variant of Raine syndrome.

F. Glorieux, K. Ozono, Y. Imanishi, 2014, Bone.

FGF-23, Left Ventricular Hypertrophy, and Mortality in Patients With CKD

M. Nangaku, Y. Kinoshita, H. Kato, 2023, JACC. Advances.